Dapavir Trademark Details

Dapavir was registered on Tuesday, October 27, 2009 and is currently owned by Rfs Pharma, LLC under the registration number 3702756 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 7 years ago on Friday, June 3, 2016, according to the United State Patent & Trademark Office
Word Mark Dapavir
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Rfs Pharma, LLC of Tucker, GA

View all trademarks for Rfs Pharma, LLC
Other Trademarks for Rfs Pharma, LLC
Serial Number 77500604
Registration Number 3702756
Status Date Friday, June 3, 2016
Filing Date Friday, June 3, 2016
Registration Date Tuesday, October 27, 2009
Attorney David Bradin

Correspondent

DAVID BRADIN
IPTL
PO BOX 14329
RESEARCH TRIANGLE PARK, NC 27709-4329

Case File Statements

Goods & Services Antivirals; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, June 3, 2016
First Use Anywhere Monday, July 20, 2009
First Use In Commerce Monday, July 20, 2009
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.